The Original And Leading Annual Forum For Personalized Medicine

Recognized Authorities And Experts Across Healthcare And Biotechnology Sectors

Broadest And Most Up-To-Date Content Across All Facets Of Precision Medicine In A Collegial Atmosphere

The Original And Leading Annual Forum For Personalized Medicine

Recognized Authorities And Experts Across Healthcare And Biotechnology Sectors

Broadest And Most Up-To-Date Content Across All Facets Of Precision Medicine In A Collegial Atmosphere

2009

Established

10,000

Attendees

1,500

Speakers

1,250

Companies

Conference Co-Hosts

“PMWC has created an outstanding forum that touches every component of precision medicine and convenes all of its stakeholders.

I am honored to be part of this experience and to be able to influence the structure and focus of the upcoming PMWC 2017 SV conference.”

Keith Yamamoto, PhD, PMWC 2017 Silicon Valley Program Chair

Professor UCSF, Vice Chancellor for Science Policy and Strategy, Vice Dean for Research, School of Medicine

Session Themes

How To Engage Community Oncologists in Precision Medicine

Session Co-Chairs: Lincoln Nadauld, Intermountain Health Care; Laurence Marton, PMWC 2014 Program Chair

Companion Diagnostics: Where is the Incentive?

Session Chair: Ed Winnick, GenomeWeb

Immunotherapy: Emerging Applications and Therapies

Session Chair: James Allison, MD Anderson Cancer Center

Integrating Precision Medicine: Technical Challenges and Solutions

Session Chair: Eric Dishman, NIH

The Economics of Bringing Precision Medicine to the Clinic

Session Chair: George Poste, ASU

Genetic Testing In Healthy Population

Session Chair: Randy Scott, Invitae

Human Biospecimen Acquisition; Risks, Challenges and Solutions

Session Chair: Matt McLoughlin, Scientist.com

ME/CFS: The Mysterious Illness Science Has Yet to Unravel

Session Chair: Zaher Nahle, Solve ME/CFS Initiative

Adoption of Precision Medicine: Hereditary Cancer

Session Chair: Taylor Sittler, Color Genomics

CIAPM: Accelerating Precision Medicine Advances in California

Session Chair: Elizabeth Baca, Governor’s Office of Planning and Research; Uta Grieshammer, CIAPM

How to Commercialize Disruptive Technologies That Advance Precision Medicine

Session Chair: Alex De Winter, GE Ventures

Let’s talk mHealth And Telehealth And Their Impact On Our Lives

Session Chair: Ida Sim, UCSF

Tumor Profiling to Clinical Action

Session Chair: Wolfgang Daum, Toma Biosciences

Scaling the 26-Hour Genome

Session Chair: Pieter van Rooyen, Edico Genome

Patient Power: The Changing Role of Individuals

Session Chair: Cliff Reid, Genos Research

Progress in Improving the Evidence Base and Insurer Coverage

Session Chair: Kathryn Phillips, UCSF

Medical Devices and IoT: the Bridge to the Phenotype

Session Chair: Sanjay Joshi, Dell EMC

An Update on the Cancer Moonshot Blood Profiling Atlas

Session Chair: Bruce Press, Seven Bridges

An Update on the Cancer Moonshot and Brain Government Initiatives

Session Chair: Joshua Gordon, National Institute of Mental Health

Data Sharing: Patient Rights and Privacy

Session Chair: William Knox Carey, Genecloud

Enabling Advances in Human Microbiome Research

Session Chair: Nick Conley, Epibiome

Biobanking Your Future

Session Chair: Nazneen Aziz, Kaiser Permanente

Health Systems as Translational Research Partners

Session Chair: Walter “Buzz” Stewart, Sutter Health

How Molecular Subtyping Can Aid Clinical Drug Development

Session Chair: Janusz Dutkowski, Data4Cure

Precision Measurement in Biology

Session Chair: Stephen Quake, Stanford University

NGS: Implementing a Clinical Workflow for All Constituents

Session Chair: Matthew Tindall, Omicia

Understanding Human Health and Diseases at the Individual Level

Session Chair: Euan Ashley, Stanford Clinical Genomics Service

Learnings from Precision Medicine Centers

Session Chair: Berta Strulovici, Weizmann Institute

How to Make Rx-Dx Alliances Work

Session Chair: Myla Lai-Goldman, GeneCentric; Eric Lai, Takeda

The Value of Data Sharing

Session Chair: John Leite, Illumina; John Shon, Illumina

Population Precision Medicine

Session Chair: Kirsten Bibbins-Domingo, UCSF

Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges

Session Chair: Walter Koch, Roche

Personalized Medicine – The Cinderella Story of Venture Investments?

Session Chair: Mara Aspinall, Genepeeks

How Immuno-oncology Saved My Life: A Patient’s Perspective

Session Chair: Andrew Schorr, Patient Power

Developing Successful Predictive Clinical Biomarkers

Session Chair: Ann Kapoun, Oncomed

Achieving Accurate NGS Test Results

Session Chair: Russell Garlick, SeraCare

Clinical Trials in Immunotherapy Session Chair: Patrice Hugo, Q2 Solutions

Clinical Trials in Immunotherapy

Session Chair: Patrice Hugo, Q² Solutions

Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology

Session Chair: Brad Gray, NanoString Technologies

Generating Insights from Multi-modal Healthcare Data for Precision Medicine

Session Chair: Atul Butte, UCSF

Issues and Challenges of Immunotherapy

Session Chair: Larry Corey, Fred Hutchinson Cancer Research Center

The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care

Session Chair: Assaf Halevy, 2bPrecise

Implementing Precision Medicine Programs: Real-world Solutions to Practical Challenges

Session Chair: Chris Cournoyer, N-of-One

Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine

Session Chair: John Ryals, Metabolon

Unlocking Real-World Clinical Data

Session Chair: Amy Abernethy, Flatiron Health

Emerging Themes in the Human Microbiome

Session Chair: Michael Fischbach, UCSF

Immunotherapy: Immunocheckpoint Inhibitors & Beyond

Session Chair: Irv Weissman, Stanford School of Medicine

Expanding the Reach of Genomic Analysis

Session Chair: Deanna Church, 10x Genomics

Precision Medicine Patent Law Update

Session Chairs: Catherine Polizzi, Morrison and Foerster and Michael Shuster, Fenwick & West

New Healthcare Paradigm from the $100 Genome

Session Chair: Yiwu He, BGI

Beyond Genomics for Predicting Patient Response

Session Chair: Parker Cassidy, Mitra Biotech

Building Value for Liquid Biopsies in Oncology

Session Chair: Frederic Pla, Genomic Health

Large Scale Human Genetics in Genomic Medicine and Drug Discovery

Session Chair: Aris Baras, Regeneron

Rare Disease Drug Development in Precision Medicine

Session Chair: Mary Dixon Drake, Innovenn

Clinical Next-Gen Sequencing for Infectious Disease Diagnosis

Session Chair: Charles Chiu, UCSF

Diagnostics Policy and the Impact on Innovation

Session Chair: Michael W. Nall, Biocept

Pathogen Specific Biologics for Infectious Diseases

Session Chair: Steven J. Projan, Medimmune

Importance of Standardized Assays for Precision Medicine

Session Chair: Jeffrey Edward Miller, Invivoscribe

Complementary Use of Digital PCR and NGS in Cancer Liquid Biopsy

Session Chair: George Karlin-Neumann, BioRad

Moving Precision Medicine to Precision Health

Session Chair: Harold L. Paz, Aetna

Clinical Applications of ctDNA in Cancer Management

Session Chair: Clive Morris, Inivata

Next-Generation Liquid Biopsy Testing: Promise and Limitations

Session Chair: Jason Myers, ArcherDX

Emerging Infections: Tracking, Testing and Public Health Response

Session Chair: Steve Miller, UCSF

Advancing the Clinic with Emerging NGS Technologies

Session Chair: Allison Ballmer, Roche

How To Engage Community Oncologists in Precision Medicine

Session Co-Chairs: Lincoln Nadauld, Intermountain Health Care; Laurence Marton, PMWC 2014 Program Chair

Companion Diagnostics: Where is the Incentive?

Session Chair: Ed Winnick, GenomeWeb

Immunotherapy: Emerging Applications and Therapies

Session Chair: James Allison, MD Anderson Cancer Center

Integrating Precision Medicine: Technical Challenges and Solutions

Session Chair: Eric Dishman, NIH

The Economics of Bringing Precision Medicine to the Clinic

Session Chair: George Poste, ASU

Genetic Testing In Healthy Population

Session Chair: Randy Scott, Invitae

Human Biospecimen Acquisition; Risks, Challenges and Solutions

Session Chair: Matt McLoughlin, Scientist.com

ME/CFS: The Mysterious Illness Science Has Yet to Unravel

Session Chair: Zaher Nahle, Solve ME/CFS Initiative

Adoption of Precision Medicine: Hereditary Cancer

Session Chair: Taylor Sittler, Color Genomics

CIAPM: Accelerating Precision Medicine Advances in California

Session Chair: Elizabeth Baca, Governor’s Office of Planning and Research; Uta Grieshammer, CIAPM

How to Commercialize Disruptive Technologies That Advance Precision Medicine

Session Chair: Alex De Winter, GE Ventures

Let’s talk mHealth And Telehealth And Their Impact On Our Lives

Session Chair: Ida Sim, UCSF

Tumor Profiling to Clinical Action

Session Chair: Wolfgang Daum, Toma Biosciences

Scaling the 26-Hour Genome

Session Chair: Pieter van Rooyen, Edico Genome

Patient Power: The Changing Role of Individuals

Session Chair: Cliff Reid, Genos Research

Progress in Improving the Evidence Base and Insurer Coverage

Session Chair: Kathryn Phillips, UCSF

Medical Devices and IoT: the Bridge to the Phenotype

Session Chair: Sanjay Joshi, Dell EMC

An Update on the Cancer Moonshot Blood Profiling Atlas

Session Chair: Bruce Press, Seven Bridges

An Update on the Cancer Moonshot and Brain Government Initiatives

Session Chair: Joshua Gordon, National Institute of Mental Health

Data Sharing: Patient Rights and Privacy

Session Chair: William Knox Carey, Genecloud

Enabling Advances in Human Microbiome Research

Session Chair: Nick Conley, Epibiome

Biobanking Your Future

Session Chair: Nazneen Aziz, Kaiser Permanente

Health Systems as Translational Research Partners

Session Chair: Walter “Buzz” Stewart, Sutter Health

How Molecular Subtyping Can Aid Clinical Drug Development

Session Chair: Janusz Dutkowski, Data4Cure

Precision Measurement in Biology

Session Chair: Stephen Quake, Stanford University

NGS: Implementing a Clinical Workflow for All Constituents

Session Chair: Matthew Tindall, Omicia

Understanding Human Health and Diseases at the Individual Level

Session Chair: Euan Ashley, Stanford Clinical Genomics Service

Learnings from Precision Medicine Centers

Session Chair: Berta Strulovici, Weizmann Institute

How to Make Rx-Dx Alliances Work

Session Chair: Myla Lai-Goldman, GeneCentric; Eric Lai, Takeda

The Value of Data Sharing

Session Chair: John Leite, Illumina; John Shon, Illumina

Population Precision Medicine

Session Chair: Kirsten Bibbins-Domingo, UCSF

Bringing Liquid Biopsy to the Clinic: Overcoming Fundamental Challenges

Session Chair: Walter Koch, Roche

Personalized Medicine – The Cinderella Story of Venture Investments?

Session Chair: Mara Aspinall, Genepeeks

How Immuno-oncology Saved My Life: A Patient’s Perspective

Session Chair: Andrew Schorr, Patient Power

Developing Successful Predictive Clinical Biomarkers

Session Chair: Ann Kapoun, Oncomed

Achieving Accurate NGS Test Results

Session Chair: Russell Garlick, SeraCare

Clinical Trials in Immunotherapy

Session Chair: Patrice Hugo, Q² Solutions

Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology

Session Chair: Brad Gray, NanoString Technologies

Generating Insights from Multi-modal Healthcare Data for Precision Medicine

Session Chair: Atul Butte, UCSF

Issues and Challenges of Immunotherapy

Session Chair: Larry Corey, Fred Hutchinson Cancer Research Center

The Last Clinical Mile of Precision Medicine – Challenges at the Point of Care

Session Chair: Assaf Halevy, 2bPrecise

Implementing Precision Medicine Programs: Real-world Solutions to Practical Challenges

Session Chair: Chris Cournoyer, N-of-One

Emerging Technologies Hold Promise to Inform the Practice of Precision Medicine

Session Chair: John Ryals, Metabolon

Unlocking Real-World Clinical Data

Session Chair: Amy Abernethy, Flatiron Health

Emerging Themes in the Human Microbiome

Session Chair: Michael Fischbach, UCSF

Immunotherapy: Immunocheckpoint Inhibitors & Beyond

Session Chair: Irv Weissman, Stanford School of Medicine

Expanding the Reach of Genomic Analysis

Session Chair: Deanna Church, 10x Genomics

Precision Medicine Patent Law Update

Session Chairs: Catherine Polizzi, Morrison and Foerster and Michael Shuster, Fenwick & West

New Healthcare Paradigm from the $100 Genome

Session Chair: Yiwu He, BGI

Beyond Genomics for Predicting Patient Response

Session Chair: Parker Cassidy, Mitra Biotech

Building Value for Liquid Biopsies in Oncology

Session Chair: Frederic Pla, Genomic Health

Large Scale Human Genetics in Genomic Medicine and Drug Discovery

Session Chair: Aris Baras, Regeneron

Rare Disease Drug Development in Precision Medicine

Session Chair: Mary Dixon Drake, Innovenn

Clinical Next-Gen Sequencing for Infectious Disease Diagnosis

Session Chair: Charles Chiu, UCSF

Diagnostics Policy and the Impact on Innovation

Session Chair: Michael W. Nall, Biocept

Pathogen Specific Biologics for Infectious Diseases

Session Chair: Steven J. Projan, Medimmune

Importance of Standardized Assays for Precision Medicine

Session Chair: Jeffrey Edward Miller, Invivoscribe

Complementary Use of Digital PCR and NGS in Cancer Liquid Biopsy

Session Chair: George Karlin-Neumann, BioRad

Moving Precision Medicine to Precision Health

Session Chair: Harold L. Paz, Aetna

Clinical Applications of ctDNA in Cancer Management

Session Chair: Clive Morris, Inivata

Next-Generation Liquid Biopsy Testing: Promise and Limitations

Session Chair: Jason Myers, ArcherDX

Emerging Infections: Tracking, Testing and Public Health Response

Session Chair: Steve Miller, UCSF

Advancing the Clinic with Emerging NGS Technologies

Session Chair: Allison Ballmer, Roche

Testimonials

See PMWC talk & session videos

“PMWC has proven, time and time again, that it attracts thought-leaders from all the relevant fields and catalyzes crucial collaboration through inspiring and practical program content. This is the Conference for entrepreneurs to meet payors, and for researchers to connect with service providers and for clinicians to hear from leading providers.”

Lee Hood, PhD, MD

President, Institute for Systems Biology

“PMWC provides a valuable insight for physicians and others who may be wondering how close we are getting to realizing the arrival of personalized medicine. The conferences are helpful in understanding where and how the envelope is being pushed.”

Peter Paul Yu, MD, FACP, FASCO

Immediate Past President, ASCO

“PMWC is a very well organized conference based in Silicon Valley that addresses all of the salient issues facing personalized medicine and offers emerging personalized medicine companies a chance to showcase their latest innovations, reminding us how exciting the field is.”

Ed Abrahams, PhD

President, PMC

Get Updates